FDA OKs Army’s diagnostic tool for skin disease

By

The Associated Press

KABUL, AFGHANISTAN – MAY 15: Afghans recieve treatment for a tropical skin disease at a clinic on May 15, 2010 south of Kabul, Afghanistan. The Afghan capital, Kabul, has one of the highest concentrations of the disfiguring skin disease, Cutaneous leishmaniasis, which is a parasitic disease transmitted by the phlebotomine sand fly. The World Health Organization estimated the number of cases in Kabul jumped from 17,000 in early 2000 to around 65,000 in 2009; the disease is non-lifethreatening and treatable with medication. (Photo by Majid Saeedi/Getty Images)

FREDERICK, Md. (AP) — Army scientists at Fort Detrick are hailing the Food and Drug Administration’s approval of a tool they helped develop for rapidly diagnosing a disfiguring skin disease caused by sand fly bites in the Middle East.

The U.S. Army Medical Research and Materiel Command said Friday that the hand-held dipstick can produce results within 30 minutes. The previous method depended on laboratory tests of skin-lesion samples that often had to be shipped to the United States.

Lt. Col. Jeanne Norwood says rapid diagnosis means quicker treatment for the disease, called cutaneous leishmaniasis (kyoo-TAY’-nee-us LEESH’-mah-nye-ah-sis), or CL.

The Army says the disease affects millions worldwide, including U.S. service members. The World Health Organization reported a major outbreak in Afghanistan in 2010.

The device is made by Seattle-based InBios International Inc.